Colzyx

About:

Colzyx is based on ground breaking and innovative discoveries from the Medical Faculty at Lund University.

Website: http://www.colzyx.com

Top Investors: European Innovation Council, EASME - EU Executive Agency for SMEs

Description:

Colzyx is based on ground breaking and innovative discoveries from the Medical Faculty at Lund University, Lund, Sweden. Their scientific work demonstrates that the alpha-3 chain from the human collagen VI molecule exhibits unprecedented wound healing and antimicrobial effects. These are used in Colzyx´ product development of novel and unique forms of bioactive wound dressings. They utilize naturally occurring, powerful biological regeneration mechanisms to accelerate the wound healing process and to protect the patient against the whole spectrum of common and multidrug-resistant bacteria.

Total Funding Amount:

$2.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Lund, Skane Lan, Sweden

Founded Date:

2016-01-01

Founders:

Karin Bryder

Number of Employees:

1-10

Last Funding Date:

2019-10-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai